Author: "Colomer R" / Database: Journals@OVID - Searchworks@Jio Institute Digital Library Search Results

Searchworks

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources

Your search keyword '"Colomer R"' showing total 15 results

Start Over Author "Colomer R" Database Journals@OVID

15 results on '"Colomer R"'

1. ADDING PERTUZUMAB IN NEOADJUVANT TREATMENT OF PATIENTS WITH HER2+ BREAST CANCER IN SPAIN: A COST OFFSETS STUDY: C070

Author: Albanell, J., Ciruelos, E., Colomer, R., De la Haba, J., Martín, M., De Salas-Cansado, M., Muñoz-Molina, B., Tournier, C., Thuresson, P., and Schleich, W.
Published: 2015

2. Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer

Author: Albanell, J., González, A., Ruiz-Borrego, M., Alba, E., García-Saenz, J. A., Corominas, J. M., Burgues, O., Furio, V., Rojo, A., Palacios, J., Bermejo, B., Martínez-García, M., Limon, M. L., Muñoz, A. S., Martín, M., Tusquets, I., Rojo, F., Colomer, R., Faull, I., and Lluch, A.
Published: 2012
Full Text: View/download PDF

3. Novel anti-fatty acid synthase compounds with anti-cancer activity in HER2+ breast cancer

Author: Oliveras, G., Blancafort, A., Urruticoechea, A., Campuzano, O., Gómez-Cabello, D., Brugada, R., López-Rodríguez, M. L., Colomer, R., and Puig, T.
Published: 2010
Full Text: View/download PDF

4. Treatment of cancer with oral drugs: a position statement by the Spanish Society of Medical Oncology (SEOM)

Author: Colomer, R., Alba, E., González-Martin, A., Paz-Ares, L., Martín, M., Llombart, A., Rodríguez Lescure, Á., Salvador, J., Albanell, J., Isla, D., Lomas, M., Rodríguez, C. A., Trigo, J. M., Germà, J. R., Bellmunt, J., Tabernero, J., Rosell, R., Aranda, E., Cubedo, R., and Baselga, J.
Published: 2010

5. Non-pegylated liposomal doxorubicin combined with gemcitabine as first-line treatment for metastatic or locally advanced breast cancer. Final results of a phase I/II trial

Author: Del Barco, S., Colomer, R., Calvo, L., Tusquets, I., Adrover, E., Sánchez, P., Rifà, J., De la Haba, J., and Virizuela, J. A.
Published: 2009

6. Low-scale phosphoproteome analyses identify the mTOR effector p70 S6 kinase 1 as a specific biomarker of the dual-HER1/HER2 tyrosine kinase inhibitor lapatinib (Tykerb®) in human breast carcinoma cells

Author: Vazquez-Martin, A., Oliveras-Ferraros, C., Colomer, R., Brunet, J., and Menendez, J. A.
Published: 2008

7. Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel

Author: Aapro, M., Abrahamsson, P. A., Body, J. J., Coleman, R. E., Colomer, R., Costa, L., Crinò, L., Dirix, L., Gnant, M., Gralow, J., Hadji, P., Hortobagyi, G. N., Jonat, W., Lipton, A., Monnier, A., Paterson, A. H. G., Rizzoli, R., Saad, F., and Thürlimann, B.
Published: 2008

8. Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells

Author: Vazquez-Martin, A., Colomer, R., Brunet, J., Lupu, R., and Menendez, J. A.
Published: 2008

9. It Is Not Time to Stop Progesterone Receptor Testing in Breast Cancer

Author: Colomer, R, Beltran, M, Dorcas, J, Cortes-Funes, H, Hornedo, J, Valentin, V, Vargas, C, Mendiola, C, and Ciruelos, E
Published: 2005
Full Text: View/download PDF

10. Usefulness of antibiotic-lock technique in management of oncology patients with uncomplicated bacteremia related to tunneled catheters

Author: Sánchez-Muñoz, A., Aguado, J. M., López-Martín, A., López-Medrano, F., Lumbreras, C., Rodríguez, F. J., Colomer, R., and Cortés-Funes, H.
Published: 2005
Full Text: View/download PDF

11. Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin™) in breast cancer cells with Her-2/neu oncogene amplification

Author: Menendez, J. A., Vellon, L., Colomer, R., and Lupu, R.
Published: 2005

12. Dietary fatty acids regulate the activation status of Her-2/neu (c-erbB-2) oncogene in breast cancer cells

Author: Menendez, J. A., Ropero, S., Lupu, R., and Colomer, R.
Published: 2004

13. Validation of the 2001 St Gallen Risk Categories for Node-Negative Breast Cancer Using a Database From the Spanish Breast Cancer Research Group (GEICAM)

Author: Colomer, R, Viñas, G, Beltran, M, Izquierdo, A, Lluch, A, Llombart-Cussac, A, Alba, E, Munárriz, B, and Martín, M
Published: 2004
Full Text: View/download PDF

14. Biweekly paclitaxel plus gemcitabine in advanced breast cancer: phase II trial and predictive value of HER2 extracellular domain

Author: Colomer, R., Llombart-Cussac, A., Lluch, A., Barnadas, A., Ojeda, B., Carañana, V., Fernández, Y., García-Conde, J., Alonso, S., Montero, S., Hornedo, J., and Guillem, V.
Published: 2004

15. Biweekly vinorelbine and gemcitabine: a phase I dose-finding study in patients with advanced solid tumors

Author: Castellano, D., Hitt, R., Ciruelos, E., Cortés-Funes, H., and Colomer, R.
Published: 2003

Catalog

Books, media, physical & digital resources

See catalog results